Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
Kyntra Bio Inc KYNB
$6.70
▼ -3.04%
($-0.21)
Open
$6.84
Prev Close
$6.91
Day Range
$6.65 – $6.85
52W Range
$4.85 – $12.60
Market Cap
$27.12M
P/E (TTM)
0.17
Beta
1.05
EPS (TTM)
$40.46
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-11-14 |
| Shares Out. | 4,050,000 |
| Website | kyntrabio.com/home ↗ |
| Phone | 14159781200 |
Kyntra Bio Inc is a publicly traded company under the ticker symbol KYNB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-06-01)